Delivery Order SPE2DB20D1004-SPE2DB25FNJSV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,373.74 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count package) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $1.75K to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qulipta 60 mg tablets (quantity: 30 units) valued at $7,886.20. This firm fixed-price delivery order, which will be completed by July 31, 2025, represents a non-competitive award under the contractor's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract. The order, valued at $2,400.59, represents a competitive award with no set-aside designation and a completion deadline of July 28, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Qulipta 60 mg tablets (30-count packages) with a contract ceiling value of $5,993.70. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The ultimate completion date is set for July 23, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,372.82 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,694.51, is for the delivery of 4,568,104,420 units of the medication Qulipta 60 mg tablet. The contract has a firm fixed price and is not a set-aside procurement. It has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.72 delivery order contract is for the supply of the medication Qulipta 60 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 21, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Qulipta 30 mg tablets. The contract has a firm fixed price of $4,752.14 and an ultimate completion date of August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Qulipta 60 mg tablets. The award has a total ceiling value of $3,083.48 and a performance period through April 23, 2025. This order is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJSVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets in a quantity of 30 units, valued at $7,459.83. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime pharmaceutical contract vehicle enables AmerisourceBergen to supply a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and the Defense Health Agency worldwide. The Qulipta tablet delivery supports DLA's medical supply chain operations and reflects the company's established role as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 7/29/25 |